INTRODUCTION
Ramadan is a lunar month during which Muslims are prescribed fasting for moral and spiritual reasons. As more than one billion people worldwide believe in Islam, it is estimated that hundreds of millions of people observe the Ramadan fast each year. 1 Ramadan fasting differs from regular voluntary or experimental fasting by the fact that Muslims do not eat, drink or smoke from dawn to sunset, which may be less or more than 12 h. 2 During this month, there are changes in the quality of food and eating patterns and people consume more carbohydrates and sweet foods after sunset.
It has been demonstrated that dietary patterns may induce a significant impact on vascular reactivity and endothelial function. 3, 4 In addition, fasting during Ramadan is mainly a radical change in life style that may affect cardiovascular risk in patients with coronary artery disease and cerebrovascular disease. 5 Cardiovascular diseases are the main cause of mortality throughout the world. Furthermore, endothelial dysfunction is one of the primary events in cardiovascular diseases. 6 The vascular endothelium has a crucial role in the regulation of vascular tone, platelet activity and blood flow. Endothelial dysfunction is the disruption of vasoregulatory functions in which anticoagulant and anti-inflammatory properties of the endothelium are altered and vascular growth is impaired. 7, 8 Nitric oxide (NO), which is produced by the endothelial isoform of NO synthase, is a key signaling mediator of the cardiovascular system and the main substance released from vascular endothelium. A sufficient level of NO is required for the normal physiology of endothelium as well as maintenance of vascular integrity; and diminished NO bioavailability may lead to endothelial dysfunction. 9 Studies have shown that asymmetric dimethylarginine (ADMA), an analog of L-arginine, is a naturally occurring endogenous inhibitor of NOS. ADMA reduces production of NO and consequently leads to endothelial dysfunction and cardiovascular abnormalities. Increasing data about the pathophysiology of endothelial dysfunction have suggested ADMA as an important risk factor for cardiovascular diseases. [10] [11] [12] Moreover, recent studies revealed that NO mediates the functions of the vascular endothelial growth factor (VEGF). VEGF is an endothelial-specific protein, which stimulates angiogeneseis, vascular permeability and vasodilation. 13 VEGF increases the production of NO as well as endothelial isoform of NO synthase expression in vascular endothelial cells in vitro and in vivo.
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On the other hand, increased oxidative stress has been linked with endothelial dysfunction in atherosclerosis and may have an important role in the pathogenesis of cardiovascular events. Reactive oxygen species may modify endothelial functions by a 1 variety of mechanisms such as peroxidation of membrane lipids and interference with availability of NO. Malondialdehyde (MDA), as an end product of lipid peroxidation, is widely used in determining oxidative stress and many studies showed increased serum levels of MDA in cardiovascular diseases. 16 During Ramadan, Muslims fast because of religious beliefs. They have to fast as long as fasting does not harm their health. Cardiovascular diseases occur in a large cohort of patients in Islamic countries and physicians recommend these patients against fasting because of possible medical concerns. In this study, we aimed to investigate the effects of fasting on cardiovascular patients by measuring markers such as NO, ADMA, VEGF and MDA in order to answer the question that 'is Ramadan fasting harmful for cardiovascular patients or not'.
MATERIALS AND METHODS Subjects
Twenty-one male patients (mean age: 52 ± 9 years) were included in this study. All patients were recruited from the Shahid-Madani Heart Hospital in Tabriz, a northwest city in Iran. Inclusion criteria were male patients between 40 and 65 years old with a documented previous history of either coronary artery disease, cerebrovascular or peripheral arterial diseases in the past 10 years and who were fasting for more than 25 days during the period from 10 July 2013 to 9 August 2013. Diagnosis of cardiovascular disease was based on a cardiologist's decision. Dietary patterns of participants during this period were almost the same including highcarbohydrate diet and foods rich in vitamins and antioxidants such as fruits and vegetables and a low-fatty diet. Exclusion criteria in this study include pregnant and lactating women, smoker subjects, patients with any type of acute inflammation (high sensitivity C-reactive protein >5), kidney diseases, diabetes and malignant tumors. Potential volunteers were first requested to complete a screening questionnaire; eligible volunteers were then screened before participation and the study design and requirements were thoroughly explained to them. Approval for this study was granted by the ethical committee of Tabriz University of Medical Sciences and the informed written consent was obtained from all subjects.
Sample collection and preservation
Approximately 10 ml of venous blood sample was obtained at 0800 hours from all participants, 2 days before and after Ramadan. The serums of samples were separated with centrifuging at 4°C for 10 min at 2500 r.p.m. and were kept frozen at − 80°C until testing. Serum samples were not stored for longer than 2 months and were thawed at room temperature only once at the time of testing.
Determination of serum NO level: Griess method NO levels were determined using the Griess method that was described previously. 17 In this method, serum NO levels were quantified indirectly by assaying NO 3 plus NO 2 (NO metabolites; NOx) after conversion of NO 3 to NO 2 by Griess reagents, using a spectrophotometric method at 540 nm; the intersample coefficient of variation and intraday variation on measurements carried out on the same sample were as low as 2.5%.
ADMA and VEGF measurement: ELISA
The serum contents of ADMA and VEGF were measured by the enzyme immunoassay procedure and enzyme-linked immunosorbent assay (ELISA). ADMA Human ELISA kit (BioVendor Laboratory Medicine, Brno, Czech Republic) was used to analyze ADMA concentration in serum samples; the intra-and inter-assay coefficient of variation were 5.7% and 8.3%, respectively. The measurement of VEGF was performed using VEGF human ELISA kit (Abcam, Cambridge, MA, USA). ELISA tests were performed in accordance with the manufacturer's instructions. The absorbance was determined at 450 nm using a micro plate reader (State Fax, 2100; Awareness Technology Inc, Palm City, FL, USA); the intra-and inter-assay coefficient of variation were below 10% and 12%, respectively.
Determination of serum MDA level: thiobarbituric acid reaction substances assay Serum MDA level was measured using the thiobarbituric acid reaction substances assay as described previously with slight modifications. 18 Briefly, 2 ml of TCA-TBA-HCl reagent (15% (w/v) TCA, 0.375% (w/v) TBA in 0.2 N HCl) was mixed with 1 ml of serum sample, and the resultant solution was heated for 20 min in a boiling water bath. After cooling, the precipitate was removed by centrifugation at 1500 r.p.m. for 10 min. The absorbance of the MDA in supernatant was measured at 535 nm spectrophotometrically; the intersample coefficient of variation and intraday variation were less than 4%.
Determination of other blood variables
The levels of fasting blood sugar, triglycerides, total cholesterol (TC), high density lipoprotein-cholesterol (HDL-C) and total protein were measured by enzymatic colorimetric method (Pars Azmoon Co, Tehran, Iran) with an automated chemical analyzer (Abbott analyzer, North Chicago, IL, USA). Low-density lipoprotein-cholesterol was calculated by using the Friedewald formula and the TC/HDL-C ratio was also estimated.
Statistical analyses
The data are reported as mean ± s.d. The Paired t-test was used to compare pre-and post-Ramadan levels of biochemical variables. The P-value of less than 0.05 was considered statistically significant.
RESULTS
A total of 31 subjects initially consented to participate in the study, but 10 dropped out and 21 male patients with a mean age of 52 ± 9 years started and completed the study for pre-and post-Ramadan blood collection. The mean years of history for cardiovascular diseases were 8.0 ± 1.5. Table 1 shows some laboratory variables of patients before and after Ramadan fasting. According to the table, triglycerides, HDL-C levels and the TC/HDL-C ratio were significantly improved after Ramadan fasting in comparison with their pre-Ramadan values. The changes in levels of FBS, TC, Low-density lipoprotein-cholesterol and the total protein after Ramadan were not significant (P>0.05).
Ramadan fasting increased NO levels of serum To evaluate the effects of Ramadan fasting on endothelial function, we measured serum NO metabolite levels through the method of Griess. Fasting during Ramadan resulted in a significant increase in NO metabolite levels in the serum of cardiovascular patients as compared with its pre-Ramadan levels (85.1 ± 11.54 vs 75.8 ± 10.7 μmol/l, Figure 1a) . 
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ADMA content decreased after Ramadan fasting ADMA was measured in this study as a marker for endothelial dysfunction. The post-Ramadan level for ADMA was lower than its pre-Ramadan level. ADMA reduction by Ramadan fasting in cardiovascular patients was statistically significant (802.6 ± 60.9 vs 837.6 ± 51.0 nmol/l, Figure 1b ).
Ramadan fasting had slight effect on VEGF levels VEGF is another biomarker measured in the present study. VEGF is recognized as a marker of angiogenesis, vascular permeability and integrity. Results showed that fasting during Ramadan had slight effects on VEGF production. Serum level of VEGF increased after Ramadan in comparison with the pre-Ramadan measurement, but the increase was not significant (228.1 ± 27.1 vs 222.7 ± 22.9 pg/ml, Figure 1c ).
MDA levels decreased during Ramadan fasting
We measured MDA as a biomarker of oxidative stress and lipid peroxidation. Ramadan fasting decreased the levels of MDA in comparison with pre-Ramadan values; however, although this decrease was not statistically significant (3.2 ± 0.7 vs 3.6 ± 1.1 μmol/l, Figure 1d ).
DISCUSSION
Fasting during Ramadan as one of the five major pillars of Islam includes similar instructions for all Muslims of any nationality and ethnicity all over the world. Dietary habits undergo significant alterations during this month due to the condition that daily calorie intake be taken in one or two meals instead of three to five meals; which mostly includes sweet foods. Previous studies showed the effects of Ramadan fasting on weight loss, blood pressure, lipid profiles and other cardiac biomarkers such as high sensitivity C-reactive protein and homocysteine. 19, 20 Two studies that were performed in Turkey and Albania reported a significant reduction in hospitalization for acute coronary syndrome during the month of Ramadan. 21, 22 Moreover, Mohler et al. 23 reported that dietary changes would affect endothelial function.
Endothelial dysfunction is a systemic disorder and the main factor in the pathogenesis of atherosclerosis. The most important characteristic of endothelial dysfunction is the reduction in the levels of vasodilators, especially NO, whereas endothelial-derived contracting factors are increased. This imbalance between vasodilators and vasoconstrictives leads to a situation that represents the functional characteristic of endothelial dysfunction. 24, 25 Reduction in NO bioavailability is mainly caused by its interaction with oxygen-derived species. Many studies have shown that calorie restriction without malnutrition by inducing a hypometabolic state increases maximal life span in diverse species. 26, 27 Bevilacqua et al. 28 reported that a reduction in reactive oxygen species generation may be a mechanism for the actions of calorie restriction. In addition, a recent study showed a significant decrease in oxidative stress markers after Ramadan fasting that may be due to dietary restriction, reduced meal frequency and decreased basal metabolic rate. 29 Schulz et al. 30 indicated that reactive oxygen species cause a fall in NO levels leading to endothelial dysfunction. In this study, NO content in cardiovascular patients increased significantly after Ramadan. Elevated NO would improve endothelial function.
The second part of our study was devoted to measuring the ADMA content as the endogenous, competitive inhibitor of NOS. All three isoforms of NOS are inhibited by the endogenous asymmetric dimethylargenine. These methylarginines are produced when arginine residues are methylated by the action of methyltransferases. 31 Thus, high levels of ADMA inhibit NO production and therefore impair endothelial function. In our hands, ADMA levels decreased significantly in the serum of cardiovascular patients after Ramadan. This is in conformity with our results that the increased amount of NO is accompanied with diminished ADMA, leading to better endothelial function. The exact mechanism by which dietary changes affect ADMA content is not clear; however, there are many studies showing the dietary modulation of endothelial dysfunction, in particular n-3 fatty acids, antioxidants, vitamins, folic acid and L-arginine. Paiva et al. 32 showed that the high amount of energy received from carbohydrates is strongly associated with low plasma ADMA concentrations, whereas a high-fat meal increases postprandial ADMA levels; these findings suggest that high-carbohydrate dietary intake during Ramadan fasting may have beneficial effects by lowering ADMA levels.
NO is a key signaling messenger in the cardiovascular system. In addition to its role as an endothelium-derived relaxing factor, it serves many important biological functions in cardiovascular physiology. NO maintains vascular integrity by inhibiting platelet aggregation, leukocyte-endothelium adhesion and vascular smooth muscle proliferation. In addition, it is produced in cardiac smooth muscle, where it regulates cardiac contractility. 33 Adequate levels of endothelial NO are important for preserving normal vascular physiology. Therefore, an increase in NO levels after Ramadan fasting has many beneficial effects for the cardiovascular system. On the other hand, ADMA inhibits vascular NO production at concentrations found in pathophysiological conditions; it also causes local vasoconstriction when it is infused intra-arterially. Increased ADMA levels are associated with reduced NO synthesis as assessed by impaired endothelium-dependent vasodilation. Thus, reduction in AMDA levels after Ramadan is a beneficial effect for patients.
VEGF is the other biomarker that was measured in this study as the indicator of endothelial integrity. VEGF is the endothelialspecific growth factor and a potent angiogenic and vascular permeabilizing factor. 13 Many studies have shown reciprocal regulation between VEGF, NO and ADMA. Fukumura et al. 13 reported that NO is a mediator for VEGF-induced angiogenesis and vascular permeability in vivo, and Dulak et al. 35 reported that endogenous NO increases the VEGF synthesis by vascular smooth muscle cells. In another study, Smith et al. 31 showed that ADMA hydrolysis increases VEGF expression by dimethylarginine dimethylaminohydrolases. In this study, we expected to observe higher levels of VEGF after Ramadan, but VEGF amount did not increase significantly and we postulated that this insignificant change may be due to the small population of test subjects in the study.
Levels of MDA in our study were decreased after Ramadan fasting, but this change was not significant statistically. The associations between oxidative stress and impaired endothelial function have been demonstrated in previous studies. Among many biological changes that occur in the vessel wall in endothelial dysfunction, the reduced bioavailability of NO in a setting of increased superoxide anion levels seems to be a uniform underlying abnormality. MDA is a naturally occurring product of lipid peroxidation and the best biomarker of oxidative stress. Soydinc et al. 36 indicated that MDA levels have a highly significant relationship with coronary artery disease as an independent effect from NO level. In addition, the high MDA levels among these patients demonstrate a relationship between the oxidative stress and atherosclerosis. 37 In conclusion, although fasting during Ramadan had a slight effect on VEGF and MDA levels, it enhanced the NO content and lowered the ADMA amount, which may result in improvement of endothelial function. Our study showed that fasting during Ramadan can have impressive effects on cardiac biomarkers, which are related to endothelial function in cardiovascular patients.
